XNCR Market Cap History
Below is a table of the XNCR market cap history going back to 12/3/2013:

Date XNCR Market Cap
12/3/2013228.45M
3/14/2014435.92M
4/30/2014310.48M
7/24/2014304.22M
11/6/2014341.58M
2/6/2015473.04M
4/24/2015594.49M
7/24/2015947.45M
10/28/2015457.79M
2/26/2016452.08M
4/26/2016545.18M
7/28/2016760.03M
10/25/2016869.26M
2/17/20171.13B
5/2/20171.14B
8/1/20171.06B
10/31/2017928.89M
2/16/20181.19B
5/4/20181.68B
8/1/20182.10B
10/31/20181.84B
2/15/20192.05B
5/2/20191.74B
8/1/20192.49B
7/22/20194.15B
10/31/20191.94B
2/14/20202.08B
4/29/20201.78B
7/30/20201.81B
10/30/20202.21B
2/16/20212.90B
4/26/20212.59B
7/28/20211.88B
11/1/20212.39B
2/16/20221.93B
4/29/20221.49B
7/29/20221.71B

Also see: XNCR Shares Outstanding History
and XNCR YTD Return
XNCR Historical Market Cap:
+26.21% CAGR
XNCR Historical Market Cap: +26.21% CAGR

Mouse over chart for data details
12/3/2013 ...7/29/2022
Xencor is a clinical-stage biopharmaceutical company focused on discovering and developing engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. Co. is developing a portfolio of clinical-stage XmAb® drug candidates from its protein engineering technology platforms. Co.'s XmAb bispecific Fc drug candidates include: Vudalimab (XmAb717), which is a bispecific antibody that targets PD-1 and CTLA-4 and for patients with metastatic castration-resistant prostate cancer and other solid tumor types; and Plamotamab, which is a bispecific antibody that targets CD20, an antigen on B-cell tumors, and CD3, an activating receptor on T cells. We show 37 historical shares outstanding datapoints in our XNCR shares outstanding history coverage, used to compute XNCR market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing XNCR market cap history over the course of time is important for investors interested in comparing XNCR's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of XNCR versus a peer is one thing; comparing XNCR market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like XNCR can fluctuate over the course of history. With this page we aim to empower investors researching XNCR by allowing them to research the XNCR market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree XNCR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Xencor (XNCR) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

XOMA Market Cap History
XON Market Cap History
XRAY Market Cap History
YMAB Market Cap History
YMTX Market Cap History
YTEN Market Cap History
ZBH Market Cap History
ZFGN Market Cap History
ZGNX Market Cap History
ZIOP Market Cap History
More Healthcare companies »

 

XNCR Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.